USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Intersurgical AG

USPTO PatentsView assignee record - 56 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Intersurgical ranks #6,036 of 49,997 tracked US assignees by granted-patent volume, with 56 patents across 18 technology areas.

#6,036
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
7.9
avg claims per patent
-31%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6036 · Foreign Corporation #6,036 · 56 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 56 grants
  • UPPER-Q #6,036/49,997
  • PHOTO-FINISH Global Blood…
  • CPC-FOCUS A61M · 18 areas
  • INNOV-THIN 36.1/100
  • CLAIMS-SPARSE 7.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -31% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Global Blood Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intersurgical’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Intersurgical

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Intersurgical's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Intersurgical?

Each dot is one of Intersurgical’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intersurgical’s own 7.9 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Intersurgical vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 55.956.056.05656.056.056.1 01020304050 Granted patents (volume) Avg claims / patent Global Blood Therapeutics, Inc. - 56, 17.14Global Blood Ther…Hobart Brothers LLC - 56, 19Hobart BrothersHP Printing Korea Co., Ltd. - 56, 17.54HP Printing KoreaIntegrity Implants Inc. - 56, 17.07Integrity ImplantsInvisage Technologies, Inc. - 56, 15.91InvisageInsyde Software Corp. - 56, 16.71Insyde SoftwareJcbd, LLC - 56, 45.62JcbdJohnson Controls Fire Protection LP - 56, 17.5Johnson Controls…Intersurgical AG - 56, 7.88Intersurgical
Intersurgical vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intersurgical's grants concentrate

Intersurgical AG is a focused PatentsView assignee: 18 CPC subclasses with 32.1% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (9 grants) versus a trough of 1 in 2023. By volume, Intersurgical sits between Global Blood Therapeutics, Inc. and Johnson Controls Fire Protection LP.

Intersurgical's three-year grant acceleration

From 2019–2021 to 2022–2024, Intersurgical AG moved from 22 to 8 grants (0.36x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Intersurgical's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Intersurgical holds 56 patents at rank #6,035, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Intersurgical

By rank, the assignees closest to #6,035 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Intersurgical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Intersurgical, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Intersurgical ranks #413 of 3,490 assignees by patent count in that subclass.

Intersurgical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018201920202021202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Intersurgical AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 9 16.1%
2016 4 7.1%
2017 6 10.7%
2018 5 8.9%
2019 8 14.3%
2020 6 10.7%
2021 8 14.3%
2023 1 1.8%
2024 7 12.5%
2025partial year 2 3.6%

Which technologies does Intersurgical AG patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Intersurgical AG's patent record in context - here's where to go next.

  • Intersurgical AG's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 32.1% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #6,036 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Intersurgical AG against Global Blood Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.